Detailed comparison of GLP-1 receptor agonists (exenatide, liraglutide) and DPP-4 inhibitors (sitagliptin, vildagliptin) covering structural chemistry, mechanism differences, pharmacology, and clinical positioning.
Key findingDetailed comparison of GLP-1 receptor agonists (exenatide, liraglutide) and DPP-4 inhibitors (sitagliptin, vildagliptin) covering structural chemistry
What the researchers found
Detailed comparison of GLP-1 receptor agonists (exenatide, liraglutide) and DPP-4 inhibitors (sitagliptin, vildagliptin) covering structural chemistry, mechanism differences, pharmacology, and clinical positioning.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
Journal of the American Pharmacists Association : JAPhA, 49 Suppl 1, S16-29
Citation
Neumiller, Joshua J. (2009). Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.. Journal of the American Pharmacists Association : JAPhA, 49 Suppl 1, S16-29. https://doi.org/10.1331/JAPhA.2009.09078